Ticker: Alaska Air to buy Hawaiian Airlines; Pfizer nixes study of obesity pill treatment
Alaska Air Group said Sunday it agreed to buy Hawaiian Airlines in a $1.9 billion deal including debt. The combined company would keep both airlines’ brands, which call the 49th and 50th states their homes. Alaska will pay $18 in cash for each share of Hawaiian, whose stock closed Friday at $4.86.…#alaskaairgroup #hawaiianairlines #alaska #hawaiian #hawaiianholdings #pfizer #novonordisk #elililly #novo (Source: Reuters: Health)
Source: Reuters: Health - December 3, 2023 Category: Consumer Health News Source Type: news

Pfizer Cancels New Weight Loss Pill After Patients Experience Serious Side Effects
Pfizer's new experimental weight-loss pill worked in achieving its stated goal — but with that weight loss came side effects so gnarly that it's shutting down the research. In a press release, the pharmaceutical giant said it was discontinuing clinical trials for danuglipron, its twice-daily…#pfizer #ozempic #danuglipron #glp1 #mikaeldolsten (Source: Reuters: Health)
Source: Reuters: Health - December 3, 2023 Category: Consumer Health News Source Type: news

Texas sues Pfizer over vaccine effectiveness claims
Texas Attorney General Ken Paxton filed a state lawsuit against pharmaceutical company Pfizer on Thursday, accusing the bio-med giant of mis­rep­re­sent­ing the efficacy of its COVID-19 vaccine. Paxton alleges Pfizer misled users when claiming the vaccine has a 95 percent effectiveness because of…#kenpaxton #pfizer #paxton (Source: Reuters: Health)
Source: Reuters: Health - December 3, 2023 Category: Consumer Health News Source Type: news

Texas Attorney General Ken Paxton sues Pfizer over vaccine claims
Texas Attorney General Ken Paxton is suing Pfizer, accusing the pharmaceutical company of lying about how effective its Covid-19 vaccine was and of not ending the pandemic as it had suggested. "The COVID-19 vaccines are the miracle that wasn’t," according to the lawsuit, filed in Lubbock County…#kenpaxton #lubbockcounty #pfizer #texastribune #gregabbott #texasstateguard #paxton (Source: Reuters: Health)
Source: Reuters: Health - December 3, 2023 Category: Consumer Health News Source Type: news

‘It wouldn’t exist’: Viagra inventor tells how Welsh miners began its rise
Dr David Brown says erectile dysfunction drug, subject of a BBC drama, could have been scrapped if a miner hadn ’t spoken outIt was the ultimate serendipitous discovery: a failed heart medication that became a multibillion-dollar erectile dysfunction drug. But the blockbuster story ofViagra could have ended differently were it not for the frankness of the Welsh miners who took part in a clinical trial just before the drug was due to be scrapped, according to Viagra ’s co-inventor.Speaking before the screening ofMen Up, a new BBC drama, executive produced by Russell T Davies, about the ordinary middle-aged Welsh men who...
Source: Guardian Unlimited Science - December 2, 2023 Category: Science Authors: Hannah Devlin Science correspondent Tags: Viagra Medical research Men's health Sex Pfizer Wales BBC Russell T Davies Pharmaceuticals industry Society UK news Source Type: news

Did Elon Musk's'GFY' Tirade Accelerate Pivot In Advertising Strategy?
Did Elon Musk's 'GFY' Tirade Accelerate Pivot In Advertising Strategy? On Thursday we emphasized in a note titled "Time To Boycott Elon's Boycotters" that when mega-corporations advertise on social media platforms or news websites, it's often less about traditional advertising and more about…#elonmusk #gfy #moderna #pfizer #dealbookconference #watchelon #nelsonepega #disney #ibm #apple (Source: Reuters: Health)
Source: Reuters: Health - December 2, 2023 Category: Consumer Health News Source Type: news

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous
FILE - The Pfizer logo is displayed at the company's headquarters, Friday, Feb. 5, 2021, in New York. Pfizer shares sank Friday, Dec. 1, 2023, when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking…#pfizer #apphoto #marklennihan #novonordisk #elililly #novo #obese #elilillys #mikaeldolsten #danuglipron (Source: Reuters: Health)
Source: Reuters: Health - December 1, 2023 Category: Consumer Health News Source Type: news

Why Pfizer's stumble in the obesity market is a boon for Eli Lilly
has suffered another setback in its efforts to develop a weight-loss pill — and that's good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss pill, danuglipron,…#club #elililly #lly #pfizer #jimcramer #sp500 #ytd #danish #novonordisk #nvo (Source: Reuters: Health)
Source: Reuters: Health - December 1, 2023 Category: Consumer Health News Source Type: news

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous
Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it (Source: ABC News: Health)
Source: ABC News: Health - December 1, 2023 Category: Consumer Health News Tags: Health Source Type: news

Pfizer to stop developing its twice-daily weight loss pill due to adverse side effects
Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies. (Source: Daily Express - Health)
Source: Daily Express - Health - December 1, 2023 Category: Consumer Health News Source Type: news

Drug giant pulls weight loss pill as obese patients suffer string of horrible side effects
Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies. (Source: Daily Express - Health)
Source: Daily Express - Health - December 1, 2023 Category: Consumer Health News Source Type: news

Bond yields continue to ease after biggest monthly drop in four years
Bond yields fell Friday, following the biggest one-month slide in long-term yields in more than four years. • The yield on the 2-year Treasury BX:TMUBMUSD02Y was 4.66%, down 4.2 basis points. Yields move in the opposite direction to prices. • The yield on the 10-year Treasury BX:TMUBMUSD10Y was…#treasury #tmubmusd10y #pfizer #federalreservechair #jeromepowell #spelmancollege #atlanta (Source: Reuters: Health)
Source: Reuters: Health - December 1, 2023 Category: Consumer Health News Source Type: news

Texas Sues Pfizer Over Vax Claims; Dr. Rand Paul to the Rescue; Kid Pneumonia Cases
(MedPage Today) -- Note that some links may require registration or subscription. Texas Attorney General Ken Paxton has sued Pfizer over the drugmaker's efficacy claims for its COVID vaccine. (Reuters) Sen. Rand Paul, MD (R-Ky.), rushed to the... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 1, 2023 Category: American Health Source Type: news

Thacker: Congress Must Hold The CDC Accountable For Cozy Ties To Pharma
Authored by Paul Thacker via The Disinformation Chronicle, Congressional leaders with the House Energy and Commerce investigative subcommittee will question CDC Director Mandy Cohen tomorrow in what should be an interesting…#paulthacker #congressional #cdc #mandycohen #rochellewalensky #walensky #houseappropriations #energyandcommerce #pfizer #vaccinecenter (Source: Reuters: Health)
Source: Reuters: Health - December 1, 2023 Category: Consumer Health News Source Type: news

Time To Boycott Elon's Boycotters
Time To Boycott Elon's Boycotters It was about four years ago that ZeroHedge went through ad monetization hell, having lost most of our advertisers because they did not approve of the content on this website and as a result they - together with such members of the Censorship Industrial Complex…#zerohedge #elonmusk #mediamatters #disney #bobiger #watchelon #nelsonepega #moderna #pfizer #glenngreenwald (Source: Reuters: Health)
Source: Reuters: Health - November 30, 2023 Category: Consumer Health News Source Type: news